Sign Up to like & get
recommendations!
1
Published in 2017 at "Nature Reviews Endocrinology"
DOI: 10.1038/nrendo.2017.33
Abstract: Loss of β-cell mass is posited to occur gradually over a long period of time in preclinical type 1 diabetes mellitus, as the first signs of β-cell autoimmunity generally emerge several years before clinical presentation.…
read more here.
Keywords:
presentation;
cell;
cell mass;
loss cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.14437
Abstract: Abstract One central factor in hepatopulmonary syndrome (HPS) pathogenesis is pulmonary vascular remodelling (PVR) which involves dysregulation of proliferation and migration in pulmonary microvascular endothelial cells (PMVECs). Growing evidence suggests that Apical/basolateral polarity plays an…
read more here.
Keywords:
cell polarity;
loss cell;
proliferation;
polarity ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-136340
Abstract: Background: Tisagenlecleucel is an anti-CD19 chimeric antigen receptor (CAR)-T cell therapy approved for pediatric and young adult patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) and adult patients with r/r diffuse large B-cell lymphoma.…
read more here.
Keywords:
loss cell;
reinfusion;
efficacy;
cell aplasia ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Life Science Alliance"
DOI: 10.26508/lsa.202201529
Abstract: This work shows that an increase in intracellular ROS through the Rac1–NOX pathway is a general response upon loss of cell–cell adhesion, which is necessary for triggering cell migration. Epithelial cells usually trigger their “migratory…
read more here.
Keywords:
cell;
cell adhesion;
loss;
loss cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24054961
Abstract: Targeting of MAP kinase pathways by BRAF inhibitors has evolved as a key therapy for BRAF-mutated melanoma. However, it cannot be applied for BRAF-WT melanoma, and also, in BRAF-mutated melanoma, tumor relapse often follows after…
read more here.
Keywords:
cell;
melanoma;
loss;
braf mutated ... See more keywords